SBIR/STTR Research Award

Lateral flow array for undeclared food allergens

Award identifier 6fe11a3206d183789616df3d476705984b95a82919ecd6fbacccf58c4075ebeaAwarding agency Department of Health and Human Services · Food and Drug Administration

Award amount

$168,087

Program and phase

SBIR · Phase I

Award year

2021

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Food and Drug Administration
Recipient company
AKONNI BIOSYSTEMS INC
Proposal award date
2021-09-20
Contract end date
2022-08-31
UEI
PGLAYC4UKDL7
Solicitation number
PA20-260
Topic code
FDA

Research abstract

PROJECT SUMMARY At least 15 million Americans and 5% of children under 5 years old suffer from food allergies. Many countries now have mandatory food labeling requirements for common allergens that are intentionally added to food products. Unfortunately, there are at least 170 known food allergens, and undeclared food allergens can accidentally contaminate a product through shared processing equipment, during transport, in storage, or because of fraud and terrorism, and result in adverse reactions or fatalities. The industry currently tests for undeclared food allergens with single-target ELISAs, high-resolution mass spectrometry, or related methods. Food processors and testing laboratories therefore continuously request and need a sensitive, specific, and easy-to-use multi-allergen test to minimize consumer health risk, and the potential for food recalls. The objective of this project is to fill this important public health technology gap by incorporating BioFrontandapos;s proprietary monoclonal allergen antibodies within Akonniandapos;s FDA-cleared Dx2000 lateral flow microarray (LFA) platform, and validating system performance within the context of MicroBacandapos;s ISO 17025-compliant food safety testing service. In Phase 1, we will verify the functionality and specificity of BioFront monoclonal antibodies in Akonniandapos;s lateral flow array; establish a test method that achieves a 1 ppm limit of detection for each of the target allergens; and demonstrate feasibility of the test with processed food extracts. These results will lay the foundation for a Phase 2 project, where we will expand the test for all remaining high-priority allergens; transfer manufacturing and packaging to Akonniandapos;s ISO13485-compliant production lines; use the platform to develop an AOAC-approved analysis method at MicroBac; validate the system for MicroBacandapos;s top 10 foods/tests; and finish all other activities required to commercialize the system and testing/analysis service(s). Completing these milestones will establish a new class of multiplexed, component-resolved allergen detection products and food testing services that are expected to improve consumer/public safety, and provide producers an affordable mechanism to comply with zero-tolerance food safety policies.PROJECT NARRATIVE Food allergens can accidentally contaminate a product through shared processing equipment, during transport, in storage, or because of intentional fraud and terrorism, resulting in adverse reactions or fatalities. This project will provide the industry with a much-needed platform and test to simultaneously detect multiple, undeclared food allergens from a single food sample. The results of this project will be new class of multiplexed, component- resolved allergen detection products and food testing services that will improve consumer/public safety, and the integrity of the US food supply.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

24 SBIR/STTR records share this UEI (2006–2022). Reported award amounts total $23,362,860. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, National Science Foundation, Department of Energy

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.